title: Response to Comments on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673-686.
authors.affiliation: Department of Endocrinology at Canberra Hospital and the Australian National University Medical School, Canberra, Australia christopher.nolan@anu.edu.au.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Nolan
authors.affiliation: Diabetes Research Unit, Boston University Medical Center, Boston, MA.
authors.forename: Neil B
authors.initials: NB
authors.lastname: Ruderman
authors.affiliation: Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System, and University of Washington, Seattle, WA.
authors.forename: Steven E
authors.initials: SE
authors.lastname: Kahn
authors.affiliation: Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
authors.forename: Oluf
authors.initials: O
authors.lastname: Pedersen
authors.affiliation: CRCHUM and Montreal Diabetes Research Center and Departments of Nutrition and Biochemistry and Molecular Medicine, University of Montreal, Quebec, Canada.
authors.forename: Marc
authors.initials: M
authors.lastname: Prentki
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D013312:Stress, Physiological / Q000187:drug effects*